Trabectedin use in soft-tissue sarcoma patients in a real-world setting: Data from an Italian national drug-access registry.

Publication Year: 2022

DOI:
10.1002/ijc.34309

PMCID:
PMC10092104

PMID:
36196483

Journal Information

Full Title: Int J Cancer

Abbreviation: Int J Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST Paolo G. Casali, Roberta Sanfilippo and Bruno Vincenzi received honoraria and institutional grants from PharmaMar. Andrea Napolitano received honoraria from PharmaMar. The other authors declare no conflict of interests."

Evidence found in paper:

"This project was developed as part of a collaboration between AIFA and the Italian Association of Medical Oncology (Associazione Italiana di Oncologia Medica, AIOM). Open Access Funding provided by Universita Campus Bio‐Medico di Roma within the CRUI‐CARE Agreement."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025